跳转至内容
Merck
CN
  • Braveheart, a long noncoding RNA required for cardiovascular lineage commitment.

Braveheart, a long noncoding RNA required for cardiovascular lineage commitment.

Cell (2013-01-29)
Carla A Klattenhoff, Johanna C Scheuermann, Lauren E Surface, Robert K Bradley, Paul A Fields, Matthew L Steinhauser, Huiming Ding, Vincent L Butty, Lillian Torrey, Simon Haas, Ryan Abo, Mohammadsharif Tabebordbar, Richard T Lee, Christopher B Burge, Laurie A Boyer
摘要

Long noncoding RNAs (lncRNAs) are often expressed in a development-specific manner, yet little is known about their roles in lineage commitment. Here, we identified Braveheart (Bvht), a heart-associated lncRNA in mouse. Using multiple embryonic stem cell (ESC) differentiation strategies, we show that Bvht is required for progression of nascent mesoderm toward a cardiac fate. We find that Bvht is necessary for activation of a core cardiovascular gene network and functions upstream of mesoderm posterior 1 (MesP1), a master regulator of a common multipotent cardiovascular progenitor. We also show that Bvht interacts with SUZ12, a component of polycomb-repressive complex 2 (PRC2), during cardiomyocyte differentiation, suggesting that Bvht mediates epigenetic regulation of cardiac commitment. Finally, we demonstrate a role for Bvht in maintaining cardiac fate in neonatal cardiomyocytes. Together, our work provides evidence for a long noncoding RNA with critical roles in the establishment of the cardiovascular lineage during mammalian development.

材料
Product Number
品牌
产品描述

Roche
X-tremeGENE 9 DNA Transfection Reagent, Polymer reagent for transfecting common cell lines